Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions
SEPN1 emerges as a novel biomarker and therapeutic target in glioma, providing a basis for future development of targeted therapies.
Authors
- Zisong Wang (ORCID: https://orcid.org/0009-0005-0357-4311)
- Danwen Wang (ORCID: https://orcid.org/0000-0003-1320-8153)
- Xiaoping Liu (ORCID: https://orcid.org/0000-0001-6179-0964)
- Yuxin Chen (ORCID: https://orcid.org/0000-0001-6254-8619)
- Zhiqiang Li (ORCID: https://orcid.org/0000-0002-0174-9254)
- Yunhe Yuan
- Xuanyu Wang (ORCID: https://orcid.org/0009-0003-2640-3086)
- Yihang Xu (ORCID: https://orcid.org/0009-0003-8617-3059)
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1371/journal.pone.0318501
- Citations
- 2
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 2.30
Funders
- National Natural Science Foundation of China
- Wuhan University
- Zhongnan Hospital of Wuhan University
- Fundamental Research Funds for the Central Universities